U.S. markets open in 8 hours 26 minutes

Achieve Life Sciences, Inc. (ACHV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.3800-0.0600 (-1.74%)
At close: 04:00PM EDT

Achieve Life Sciences, Inc.

1040 West Georgia Street
Suite 1030
Vancouver, BC V6E 4H1

Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Dr. Richard A. B. StewartExec. Chairman660kN/A1959
Mr. John A. Bencich M.B.A.CEO & Director767.25kN/A1977
Dr. Cindy Jacobs M.D., Ph.D.Pres, Chief Medical Officer & Director668.8kN/A1958
Mr. Jerry WanPrincipal Accounting OfficerN/AN/A1982
Dr. Anthony ClarkeChief Scientific OfficerN/AN/A1956
Ms. Jaime XinosExec. VP of CommercialN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Corporate Governance

Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.